Peter Heerma Insider Trading
Get free email notifications about insider trading for Peter Heerma.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Peter Heerma. Peter Heerma is a Chief Commercial Officer in Retrophin, Inc. ($RTRX).
Address: C/O RETROPHIN, INC. 3721 VALLEY CENTRE DRIVE, SUITE 200 SAN DIEGO 92130 CA
Companies in which Peter Heerma is an Insider
Travere Therapeutics, Inc.
Trading Symbol: RTRXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Peter Heerma: Chief Commercial Officer
Holdings: 61,594 shares
Current Value: $1,236,192
Latest Transaction: Feb 05 2021
$RTRX Market Capitalization: $766.34M
$RTRX Previous Close: $20.07
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Peter Heerma
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 05 2021 | RTRX | Travere Therapeuti ... | Heerma Peter | Chief Commercial Of ... | Grant | A | 0.00 | 4,500 | 0 | 61,594 | 57.1 K to 61.6 K (+7.88 %) |
Feb 05 2021 | RTRX | Travere Therapeuti ... | Heerma Peter | Chief Commercial Of ... | Grant | A | 0.00 | 4,500 | 0 | 61,594 | 57.1 K to 61.6 K (+7.88 %) |
Feb 03 2021 | RTRX | Travere Therapeuti ... | Heerma Peter | Chief Commercial Of ... | Sell | S | 28.91 | 563 | 16,276 | 57,094 | 57.7 K to 57.1 K (-0.98 %) |
Feb 03 2021 | RTRX | Travere Therapeuti ... | Heerma Peter | Chief Commercial Of ... | Sell | S | 30.75 | 563 | 17,312 | 57,657 | 58.2 K to 57.7 K (-0.97 %) |
Jan 25 2021 | RTRX | Travere Therapeuti ... | Heerma Peter | Chief Commercial Of ... | Option Exercise | A | 26.88 | 57,500 | 1,545,600 | 57,500 | |
Jan 25 2021 | RTRX | Travere Therapeuti ... | Heerma Peter | Chief Commercial Of ... | Grant | A | 0.00 | 15,000 | 0 | 58,220 | 43.2 K to 58.2 K (+34.71 %) |
Oct 05 2020 | RTRX | Retrophin, Inc. | Heerma Peter | Chief Commercial Of ... | Sell | S | 19.35 | 2,188 | 42,338 | 42,329 | 44.5 K to 42.3 K (-4.91 %) |